EMN
Eastman Chemical Co
$67.21
+0.31 (+0.46%)
At close · Jul 9
Market Cap
$7.73B
Shares
114,349,960
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$8.75B
-6.7%
FY2025
Net Income
$474M
-47.6%
FY2025
Gross Margin
21.07%
-3.3pp
FY2025
Operating Margin
16.04%
+0.7pp
FY2017
Diluted EPS
$4.10
-46.5%
FY2025
Operating Cash Flow
$970M
-24.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $8.64B | $8.75B | $9.38B | $9.21B | $10.58B | $10.48B | $8.47B | $9.27B | $10.15B | $9.55B | $9.01B | $9.65B | $9.53B | $9.35B | $8.1B | — | — | — | |
| -$211M | -$208M | -$200M | -$215M | -$182M | -$198M | -$210M | -$218M | -$235M | -$241M | -$255M | -$263M | -$187M | -$180M | -$143M | -$76M | -$99M | -$78M | |
| $6.93B | $6.91B | $7.09B | $7.15B | $8.44B | $7.98B | $6.5B | $7.04B | $7.67B | $7.1B | $6.66B | $7.07B | $7.31B | $6.57B | $6.34B | $5.61B | $4.37B | $3.99B | |
| $1.71B | $1.84B | $2.29B | $2.06B | $2.14B | $2.5B | $1.98B | $2.23B | $2.48B | $2.45B | $2.35B | $2.58B | $2.22B | $2.78B | $1.76B | $1.57B | $1.47B | $1.05B | |
| — | 21.07% | 24.41% | 22.38% | 20.2% | 23.86% | 23.31% | 24.09% | 24.42% | 25.7% | 26.09% | 26.74% | 23.31% | 29.69% | 21.75% | — | — | — | |
| $248M | $255M | $250M | $239M | $264M | $254M | $226M | $234M | $235M | $215M | $219M | $251M | $227M | $193M | $198M | $159M | $152M | $137M | |
| $654M | $658M | $736M | $727M | $726M | $795M | $654M | $691M | $721M | $699M | $703M | $762M | $755M | $645M | $644M | $481M | $431M | $399M | |
| — | $79M | $82M | $86M | $87M | $108M | $128M | $160M | $164M | $164M | $166M | $163M | $90M | $80M | $42M | $4M | — | — | |
| $518M | $513M | $509M | $498M | $477M | $538M | $574M | $611M | $604M | $587M | $580M | $571M | $450M | $433M | $360M | $273M | $280M | $274M | |
| — | — | — | — | — | — | — | — | — | — | — | $183M | $77M | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | $1.53B | $1.38B | $1.38B | $1.16B | $1.86B | $800M | $937M | $862M | $317M | |
| — | — | — | — | — | — | — | — | — | 16.04% | 15.35% | 14.34% | 12.2% | 19.91% | 9.87% | — | — | — | |
| — | — | — | — | — | — | — | — | — | $2.12B | $1.96B | $1.96B | $1.61B | $2.3B | $1.16B | $1.21B | $1.14B | $591M | |
| -$89M | -$84M | -$47M | -$38M | $6M | $17M | -$8M | -$3M | $53M | -$2M | $6M | $8M | $15M | -$3M | -$8M | $19M | -$12M | -$13M | |
| — | -$1M | $0 | $10M | $19M | $16M | $15M | $10M | $17M | $14M | $15M | $15M | $13M | $5M | — | — | — | — | |
| $451M | $568M | $1.08B | $1.09B | $977M | $1.08B | $530M | $902M | $1.31B | $1.29B | $1.05B | $1.13B | $990M | $1.68B | $649M | $880M | $636M | $226M | |
| $52M | $93M | $170M | $191M | $181M | $215M | $41M | $140M | $226M | -$99M | $190M | $275M | $235M | $507M | $206M | $274M | $211M | $90M | |
| $399M | $474M | $905M | $894M | $793M | $857M | $478M | $759M | $1.08B | $1.38B | $854M | $848M | $751M | $1.17B | $437M | $646M | $438M | $136M | |
| — | 5.42% | 9.65% | 9.71% | 7.5% | 8.18% | 5.64% | 8.19% | 10.64% | 14.49% | 9.48% | 8.79% | 7.88% | 12.46% | 5.39% | — | — | — | |
| $0 | $1M | $3M | $2M | $3M | $10M | $11M | $3M | $4M | $4M | $5M | $6M | $6M | $7M | $7M | — | — | — | |
| $579M | $628M | $910M | $780M | $770M | $948M | $419M | $770M | $1.04B | $1.46B | $963M | $735M | $303M | $1.21B | $422M | $590M | $391M | $86M | |
| USD/shares | — | $4.14 | $7.75 | $7.54 | $6.42 | $6.35 | $3.53 | $5.52 | $7.65 | $9.56 | $5.80 | $5.71 | $5.03 | $7.57 | $3.00 | $4.63 | $6.07 | $1.88 |
| USD/shares | — | $4.10 | $7.67 | $7.49 | $6.35 | $6.25 | $3.50 | $5.48 | $7.56 | $9.47 | $5.75 | $5.66 | $4.97 | $7.44 | $2.93 | $4.52 | $5.92 | $1.85 |
| shares | — | 114.7M | 116.7M | 118.6M | 123.5M | 134.9M | 135.5M | 137.4M | 141.2M | 144.8M | 147.3M | 148.6M | 149.5M | 154M | 145.5M | 139.7M | — | — |
| shares | — | 115.6M | 117.9M | 119.4M | 124.9M | 137.1M | 136.5M | 138.5M | 142.9M | 146.1M | 148.4M | 149.8M | 151.1M | 156.5M | 149.1M | 143.1M | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2009–FY2025: $900M in buybacks, $4.65B in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Specialty Chemicals median 1.91×
EV/EBIT
—
Specialty Chemicals median 27.60×
P/E (TTM)
19.53×
Specialty Chemicals median 21.03×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Additives and Functional Products | $2,880,000,000 | $2,862,000,000 | $2,834,000,000 | $3,475,000,000 | $2,949,000,000 | $2,095,000,000 | $3,273,000,000 | $3,647,000,000 |
| Advanced Materials | $2,880,000,000 | $3,050,000,000 | $2,932,000,000 | $3,207,000,000 | $3,027,000,000 | $2,524,000,000 | $2,688,000,000 | $2,755,000,000 |
| Chemical Intermediates | $1,925,000,000 | $2,134,000,000 | $2,143,000,000 | $2,716,000,000 | $2,608,000,000 | $2,090,000,000 | $2,443,000,000 | $2,831,000,000 |
| Fibers | $1,050,000,000 | $1,318,000,000 | $1,295,000,000 | $1,022,000,000 | $900,000,000 | $837,000,000 | $869,000,000 | $918,000,000 |
| All Other Segments | $17,000,000 | $18,000,000 | $6,000,000 | $160,000,000 | $992,000,000 | $927,000,000 | — | — |
| All Operating Segments | — | — | — | $10,420,000,000 | — | $7,546,000,000 | — | — |
By Geography (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| All Foreign Countries | $4,140,000,000 | $4,536,000,000 | $4,442,000,000 | $4,878,000,000 | $5,089,000,000 | $5,036,000,000 | $5,553,000,000 | $6,033,000,000 |
| United States | $3,662,000,000 | $3,773,000,000 | $3,794,000,000 | $4,738,000,000 | $4,397,000,000 | $3,437,000,000 | $3,720,000,000 | $4,118,000,000 |
| China | $950,000,000 | $1,073,000,000 | $974,000,000 | $964,000,000 | $990,000,000 | — | — | — |
Key facts
CIK
915389
CUSIP
277432100
13F (30d)
32 filings
23 filers
Visit website
Investor relations